The economic burden of lung cancer and the associated costs of treatment failure in the United States

  • Kutikova L
  • Bowman L
  • Chang S
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


The economic burden of lung cancer was examined with a retrospective case-control cohort study on a database containing inpatient, outpatient and drug claims for employees, dependents and retirees of multiple large US employers with wide geographic distribution. Patients were followed for maximum of 2 years from first cancer diagnosis until death, health benefits disenrollment or study end (31 December 2000). Compared with controls (subjects without any cancer), patients with lung cancer (n=2040) had greater health care service utilization and costs for hospitalization, emergency room visits, outpatient office visits, radiology procedures, laboratory procedures and pharmacy-dispensed drugs (all P

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in


  • Lucie Kutikova

  • Lee Bowman

  • Stella Chang

  • Stacey R Long

  • Coleman Obasaju

  • William H Crown

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free